In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, growing at an annualized rate of ~9.8%
Roots Analysis has done a detailed study on ““In Vitro ADME Testing Services Market, 2019-2030”” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

Roots Analysis has done a detailed study on ““In Vitro ADME Testing Services Market, 2019-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.


To order this 280+ page report, which features 135+ figures and 120+ tables, please visit this -


Key Market Insights

  • Over 90 firms are actively involved in providing vitro ADME testing services; of these, over 30 players claim to have the capabilities to offer end-to-end services
  • Majority of the companies offer assays for drug metabolism and elimination testing for both small molecule and biologic drugs; followed by companies offering assays for absorption and distribution testing
  • Featuring the presence of small-mid sized firms, the in vitro ADME testing service provider landscape is well-distributed across various regions; these players have adopted various business models to cater to the evolving needs of the clients
  • Several players involved in this domain are steadily expanding their capabilities in order to enhance their respective in the in vitro ADME testing service portfolios and maintain a competitive edge in this industry
  • Various mergers and acquisitions have taken place from 2005-2018 between industry stakeholders in this domain, for addition of capabilities (primarily related to drug metabolism and pharmacokinetics testing) and geographical expansion / consolidation
  • Driven by the increasing demand for effective pharmacological interventions across a wide range of therapeutic areas, the market is expected to witness sustained growth in future
  • In the long-term, the projected opportunity is anticipated to be well distributed across various geographies, type of sponsors and type of services / assays


For more information, please visit  


Table of Contents



1.1.      Scope of the Report

1.2.      Research Methodology

1.3.      Chapter Outlines





3.1.      Chapter Overview

3.2.      The Drug Discovery and Development Process

3.3.      Introduction to Absorption, Distribution, Metabolism and Excretion (ADME) Testing

3.3.1.    Absorption

3.3.2.    Distribution

3.3.3.    Metabolism

3.3.4.    Excretion


3.4.      Importance of ADME Studies in Early Stage Research

3.5.      Types of ADME Studies in Discovery and Preclinical Development

3.6.      Types of Assays Used in ADME Testing


3.7.      Types of ADME Testing Studies

3.7.1.    In Vitro ADME Testing Studies

3.7.2.    In Silico ADME Testing Studies

3.7.3.    In Vivo ADME Testing Studies


3.8.      Key Drivers for ADME Testing Studies

3.9.      Concluding Remarks



4.1.      Chapter Overview

4.2.      Outsourcing ADME Testing Services

4.3.      Guiding Models for Outsourcing

4.3.1.    Transactional Outsourcing Model

4.3.2.    Performance-based Outsourcing Model

4.3.3.    Outcomes-based Outsourcing Model

4.3.4.    Phase-dependent Outsourcing Model

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415